SUSTAINED EFFICACY IS ACHIEVED WITH REPEAT COURSES OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) WITH AN INADEQUATE RESPONSE TO ONE OR MORE TNF INHIBITORS (TNF-IR)

被引：0
|
作者：
Keystone, Edward C. [1 ]
Fleischmann, Roy M. [2 ]
Emery, Paul [3 ]
Dougados, Maxime [4 ]
Baldassare, Andrew R. [5 ]
Armstrong, Gillian K. [6 ]
Linnik, Matthew [7 ]
Reynard, Mark [6 ]
Tyrrell, Helen [6 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Leeds Gen Infirm, Leeds, W Yorkshire, England
[4] Hop Cochin, F-75674 Paris, France
[5] St Louis Univ, St Louis, MO 63103 USA
[6] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[7] Biogen Idec Inc, San Diego, CA USA
来源：
RHEUMATOLOGY | 2010年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I98 / I98
页数：1
相关论文
共 50 条
  • [31] Oral glucocorticoids have no impact on the efficacy or safety profile of rituximab in rheumatoid arthritis patients with inadequate response to TNF inhibitors (REFLEX study)
    Burmester, G. R.
    Ruderman, E. M.
    Durez, P.
    Loveless, J.
    Kvien, T. K.
    Jackson, C.
    Burke, L.
    Cravets, M.
    White, A. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 180 - 180
  • [32] Efficacy and safety of repeat treatment courses of rituximab (RTX) in RA patients (pts) with inadequate response (IR) to tumor necrosis factor (TNF) inhibitors: Long-term experience from the REFLEX 2 study
    Keystone, Edward C.
    Fleischmarm, Roy M.
    Emery, Paul
    Chubick, Andrew
    Dougados, Maxime R.
    Baldassare, Andrew R.
    Bathon, Joan M.
    Hessey, Eva
    Hagerty, David
    Safa-Leathers, Simon
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S303 - S303
  • [33] Oral glucocorticoids have no impact on the efficacy or safety profile of rituximab in rheumatoid arthitis (RA) patients with inadequate response to TNF inhibitors (REFLEX study).
    Ruderman, E. M.
    Burmester, G. R.
    Durez, P.
    Loveless, J.
    Kvien, T. K.
    Jackson, C.
    Burke, L.
    Cravets, M.
    White, A. M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S226 - S227
  • [34] Efficacy of Sarilumab Plus csDMARDs in Rheumatoid Arthritis Patients who had an Inadequate Response to One or More than One Prior TNF Inhibitor
    Genovese, Mark
    Pinheiro, Geraldo
    Mangan, Erin
    Lin, Yong
    van Adelsberg, Janet
    van Hoogstraten, Hubert
    Kimura, Toshio
    Fleischmann, Roy
    Fiore, Stefano
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 896 - 896
  • [35] EFFICACY OF SARILUMAB PLUS CSDMARDS IN RHEUMATOID ARTHRITIS PATIENTS WHO HAD AN INADEQUATE RESPONSE TO ONE OR MORE THAN ONE PRIOR TNF INHIBITOR
    Genovese, M.
    Pinheiro, G.
    Mangan, E.
    Lin, Y.
    Van Hoogstraten, H.
    Fleischmann, R.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 29 - 29
  • [36] EFFICACY OF SARILUMAB PLUS CSDMARDS IN RHEUMATOID ARTHRITIS PATIENTS WHO HAD AN INADEQUATE RESPONSE TO ONE OR MORE THAN ONE PRIOR TNF INHIBITOR
    Genovese, M. C.
    Pinheiro, G. da R. C.
    Mangan, E. K.
    Lin, Y.
    van Adelsberg, J.
    van Hoogstraten, H.
    Thompson, D.
    Fleischmann, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 730 - 731
  • [37] A NETWORK META-ANALYSIS OF BIOLOGIC TREATMENTS IN TNF-IR RHEUMATOID ARTHRITIS PATIENTS
    LeReun, C.
    Neophytou, I
    De Vries, R.
    Diamantopoulos, A.
    Pompen, M.
    VALUE IN HEALTH, 2011, 14 (07) : A303 - A303
  • [38] Repeated treatment courses of Rituximab (RTX) produce sustained efficacy in RA patients with an inadequate response to DMARDs
    Emery, Paul
    Leirisalo-Repo, Marjatta
    Ferraccioli, Gianfranco
    Udell, James
    van Vollenhoven, Ronald
    Rowe, Karen
    Reiss, William
    Shaw, Tim
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 43 - 43
  • [39] Sustained Clinical Efficacy after Multiple Courses of Rituximab in Rheumatoid Arthritis Patients with Inadequate Response to Tumor Necrosis Factor Inhibitors: 3-Year Data from Repeat.
    Codreanu, Catalin
    Ionescu, Ruxandra
    Ancuta, Ioan
    Mogosan, Corina
    Rednic, Simona
    Ciurea, Paulina
    Suta, Maria
    Parvu, Magda
    Balanescu, Andra
    Bojinca, Mihai
    Nemes, Dan
    Ancuta, Codrina
    Rezus, Elena
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S672 - S672
  • [40] Rituximab significantly improves the clinical and simplified disease activity index (CDAI, SDAI) scores in patients with rheumatoid arthritis (RA) and an inadequate response to TNF inhibitors (REFLEX)
    Smolen, J.
    Kavanaugh, A.
    Tony, H. P.
    Greenwald, M.
    De Vita, S.
    Brasington, R.
    Aletaha, D.
    White, A. M.
    Hessey, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 439 - 439
12345